13F filer · CIK 886982 ↗
Goldman Sachs Group Inc
You are looking at Q1 2019. See the latest, Q2 2026 →
Reported value
$331.01B
+5.5% on the quarter before
Positions
5,073
569 new · 684 sold out
Top 10
12.9%
of the value
Est. gain
+$32.48B
on stocks held all quarter
Est. return
+13.7%
on those stocks since Q4 2018
Positions as of Mar 31, 2019, from Goldman Sachs Group Inc's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 21% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2018. Striped tiles are options.
Largest buys
Since Q4 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- ApplePUT~$920.1MAdded · 0.1% → 0.4%+4,843,900 underlying
- Pfizer Inc~$600.9MAdded · 0.5% → 0.7%+14,149,127 shares
- Ishares TrCALL~$598.4MAdded · 0.1% → 0.3%+6,920,000 underlying
- Ishares TrPUT~$574.7MAdded · 0.2% → 0.4%+13,389,600 underlying
- Western Midstream Partners L~$417.2MNew · 0.0% → 0.1%+13,304,099 shares
- First Rep Bk San Francisco C~$403.5MAdded · 0.1% → 0.2%+4,016,449 shares
- Ishares TrCALL~$359.6MAdded · 0.1% → 0.2%+2,348,900 underlying
- Walt Disney Company (The)~$317.2MAdded · 0.2% → 0.3%+2,856,800 shares
- Ishares Tr~$310.8MAdded · 0.1% → 0.2%+2,913,269 shares
- Suntrust Bks Inc~$293.0MAdded · 0.1% → 0.2%+4,944,542 shares
Largest sells
Since Q4 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF TrCALL~$2.44BCut · 1.2% → 0.5%−8,621,500 underlying
- SPDR S&P 500 ETF TrPUT~$2.16BCut · 1.4% → 0.8%−7,654,600 underlying
- SPDR Gold TrustCALL~$1.26BCut · 0.7% → 0.3%−10,351,700 underlying
- SPDR S&P 500 ETF Tr~$1.11BCut · 3.6% → 3.6%−3,922,781 shares
- Apple~$986.2MCut · 1.7% → 1.6%−5,191,766 shares
- Alibaba~$858.5MCut · 0.9% → 0.9%−4,705,341 shares
- Ishares Tr~$751.7MCut · 0.8% → 0.5%−8,693,702 shares
- Starbucks Corp~$581.6MCut · 0.4% → 0.2%−7,822,913 shares
- Visa Inc.~$492.0MCut · 0.8% → 0.7%−3,150,090 shares
- Merck & Co Inc~$473.4MCut · 0.6% → 0.5%−5,692,149 shares
Holdings
As of Mar 31, 2019. Changes are in shares against Dec 31, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPDR S&P 500 ETF TrCMN · shares −8.6% · price +13.0% | 3.6% | $11.82B | +$1.36B | ||||||||
| AppleCMN · shares −16% · price +20.4% | 1.6% | $5.34B | +$905.5M | ||||||||
| MicrosoftCMN · shares −3.8% · price +16.1% | 1.4% | $4.54B | +$630.8M | ||||||||
| AmazonCMN · shares −3.5% · price +18.6% | 1.2% | $4.10B | +$642.2M | ||||||||
| Ishares TrCMN · shares +1.3% · price +14.3% | 0.97% | $3.20B | +$396.2M | ||||||||
| AlibabaCMN · shares −22% · price +33.1% | 0.91% | $3.02B | +$750.7M | ||||||||
| MetaCMN · shares −10% · price +27.2% | 0.91% | $3.00B | +$641.6M | ||||||||
| SPDR S&P 500 ETF TrPUTCMN · shares −44% | 0.84% | $2.78B | — | ||||||||
| Ishares TrCMN · shares −15% · price +10.3% | 0.76% | $2.51B | +$235.2M | ||||||||
| Visa Inc.CMN · shares −17% · price +18.4% | 0.71% | $2.36B | +$366.2M | ||||||||
| AlphabetCMN · shares −2.0% · price +12.6% | 0.68% | $2.26B | +$253.8M | ||||||||
| Pfizer IncCMN · shares +36% · price −2.7% | 0.68% | $2.25B | −$45.8M | ||||||||
| Energy Transfer LpCMN · shares +1.9% · price +16.4% | 0.66% | $2.19B | +$302.4M | ||||||||
| Invesco Qqq TrCMN · shares −17% · price +16.5% | 0.58% | $1.92B | +$271.9M | ||||||||
| Johnson & JohnsonCMN · shares −13% · price +8.3% | 0.57% | $1.90B | +$145.9M | ||||||||
| AlphabetCMN · shares −5.1% · price +13.3% | 0.55% | $1.83B | +$215.3M | ||||||||
| Ishares TrCMN · shares −30% · price +6.6% | 0.54% | $1.80B | +$111.6M | ||||||||
| SPDR S&P 500 ETF TrCALLCMN · shares −58% | 0.53% | $1.75B | — | ||||||||
| Ishares TrPUTCMN · shares +3.8% | 0.53% | $1.74B | — | ||||||||
| CiscoCMN · shares −6.4% · price +24.6% | 0.51% | $1.68B | +$330.9M | ||||||||
| Jpmorgan Chase & CoCMN · shares −11% · price +3.7% | 0.49% | $1.62B | +$57.7M | ||||||||
| Merck & Co IncCMN · shares −23% · price +8.8% | 0.48% | $1.59B | +$129.0M | ||||||||
| Ishares TrCMN · shares −0.5% · price +15.6% | 0.45% | $1.48B | +$199.9M | ||||||||
| Ishares TrCMN · shares +3.3% · price +11.2% | 0.44% | $1.44B | +$140.9M | ||||||||
| Enterprise Prods Partners LCMN · shares +0.8% · price +18.3% | 0.43% | $1.42B | +$218.6M | ||||||||
| Total · 5,073 positions | 100% | $331.01B | +$32.48B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2018 to Q1 2019: 3,747 stocks held throughout, up $32.48B (+13.7%).
- SPDR S&P 500 ETF Tr+$1.36B+13%
- Apple+$905.5M+20%
- Alibaba+$750.7M+33%
- Amazon+$642.2M+19%
- Meta+$641.6M+27%
- Cvs Health Corp−$69.2M−18%
- Centene Corp Del−$70.9M−54%
- Tesla−$72.4M−16%
- Biogen Inc−$107.5M−21%
- Abbvie Inc−$126.9M−13%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 11 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $1.15T+32% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $870.94B+7% | SEC ↗ |
| Q4 2025 | Mar 25, 2026 (amended) | $815.35B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $817.38B+11% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $736.09B+19% | SEC ↗ |
| Q1 2025 | Jun 27, 2025 (amended) | $617.84B−3% | SEC ↗ |
| Q4 2024 | Feb 11, 2025 | $634.40B+2% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $621.07B+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $591.35B+5% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.15B+4% | SEC ↗ |
| Q4 2023 | May 14, 2024 (amended) | $542.58B+15% | SEC ↗ |
| Q3 2023 | May 15, 2024 (amended) | $470.08B+1% | SEC ↗ |
| Q2 2023 | May 14, 2024 (amended) | $466.39B+7% | SEC ↗ |
| Q1 2023 | May 14, 2024 (amended) | $435.29B+7% | SEC ↗ |
| Q4 2022 | May 14, 2024 (amended) | $407.90B+102,967% | SEC ↗ |
| Q3 2022 | May 14, 2024 (amended) | $395.8M−1% | SEC ↗ |
| Q2 2022 | May 14, 2024 (amended) | $400.2M−100% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $476.17B−5% | SEC ↗ |
| Q4 2021 | Feb 17, 2022 (amended) | $503.62B+7% | SEC ↗ |
| Q3 2021 | Jan 20, 2022 (amended) | $471.46B+6% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $446.39B+13% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $396.45B+2% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $388.63B+10% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $352.35B+7% | SEC ↗ |
| Q2 2020 | Aug 12, 2020 | $329.38B+16% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $283.84B−28% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $392.61B+13% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $346.13B−0% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $347.49B+5% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $331.01B+6% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $313.71B−19% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $387.28B+5% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $369.55B−5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $390.88B−7% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $418.15B+2% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $408.33B+6% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $386.49B+5% | SEC ↗ |
| Q1 2017 | May 18, 2017 (amended) | $368.56B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $353.62B+7% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $330.24B+8% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $306.30B+1% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $304.14B | SEC ↗ |